A Platform to Deliver Single and Bi-specific Cas9/guide RNA to Perturb Genes in Vitro and in Vivo
Article in Molecular Therapy (July 2024)
The most recent citing publications are shown below. View all 13 publications that cite this research output on Dimensions.
An investigator-initiated clinical study in patients with refractory or recurrent solid tumors: ‘R-ISV-FOLactis’ trial
Article in Future Oncology (June 2024)
The dynamic duo: A narrative review on the synergy between stereotactic body radiotherapy and immunotherapy in lung cancer treatment (Review)
Article in Oncology Reports (June 2024)